The Foundation for Angelman Syndrome Therapeutics (FAST), led by parents, has helped redefine the role of advocacy groups and has moved beyond raising awareness to actively supporting cutting-edge research and clinical development. The organization's venture-oriented approach has been successful in attracting industry partners.